GB1235543A - Controlled release tablet - Google Patents
Controlled release tabletInfo
- Publication number
- GB1235543A GB1235543A GB04720/68A GB1472068A GB1235543A GB 1235543 A GB1235543 A GB 1235543A GB 04720/68 A GB04720/68 A GB 04720/68A GB 1472068 A GB1472068 A GB 1472068A GB 1235543 A GB1235543 A GB 1235543A
- Authority
- GB
- United Kingdom
- Prior art keywords
- controlled release
- april
- medicament
- release tablet
- carboxy polymethylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000013270 controlled release Methods 0.000 title abstract 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- 229940096529 carboxypolymethylene Drugs 0.000 abstract 2
- 239000000416 hydrocolloid Substances 0.000 abstract 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 abstract 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- HXFNRRNDWNSKFM-UHFFFAOYSA-N 3-ethenyl-5-methyl-1,3-oxazolidin-2-one Chemical compound CC1CN(C=C)C(=O)O1 HXFNRRNDWNSKFM-UHFFFAOYSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229960000244 procainamide Drugs 0.000 abstract 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 abstract 1
- 229960001404 quinidine Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62906667A | 1967-04-07 | 1967-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1235543A true GB1235543A (en) | 1971-06-16 |
Family
ID=24521437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB04720/68A Expired GB1235543A (en) | 1967-04-07 | 1968-04-07 | Controlled release tablet |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3458622A (cg-RX-API-DMAC7.html) |
| DE (1) | DE1767170A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK123071B (cg-RX-API-DMAC7.html) |
| FR (2) | FR1588801A (cg-RX-API-DMAC7.html) |
| GB (1) | GB1235543A (cg-RX-API-DMAC7.html) |
| NL (1) | NL6804772A (cg-RX-API-DMAC7.html) |
| SE (1) | SE353019B (cg-RX-API-DMAC7.html) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US3632778A (en) * | 1970-06-10 | 1972-01-04 | Hoffmann La Roche | Tablets containing l-dopa |
| CA1097220A (en) * | 1975-10-10 | 1981-03-10 | Aaron L. Weiss | Controlled release tablet |
| US4264573A (en) * | 1979-05-21 | 1981-04-28 | Rowell Laboratories, Inc. | Pharmaceutical formulation for slow release via controlled surface erosion |
| CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
| US4248857A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4273920A (en) * | 1979-09-12 | 1981-06-16 | Eli Lilly And Company | Polymerization process and product |
| US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
| US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
| DE3448522C2 (de) * | 1983-11-11 | 1995-08-24 | Egyt Gyogyszervegyeszeti Gyar | Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben |
| HU190619B (en) | 1983-11-11 | 1986-09-29 | Bezzegh,Denes,Hu | Process for producing tablets with controlled dissolution of active ingredients |
| US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| US4666705A (en) * | 1985-06-03 | 1987-05-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| DE3535536A1 (de) * | 1985-10-04 | 1987-04-09 | Lentia Gmbh | Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut |
| US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| US4738850A (en) * | 1986-05-27 | 1988-04-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
| US4772473A (en) * | 1986-06-16 | 1988-09-20 | Norwich Eaton Pharmaceuticals, Inc. | Nitrofurantoin dosage form |
| US4798725A (en) * | 1986-06-16 | 1989-01-17 | Norwich Eaton Pharmaceuticals, Inc. | Sustained release capsule |
| US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
| US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
| US5702716A (en) * | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5487897A (en) | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
| JPH03145418A (ja) * | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
| AU2605592A (en) * | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
| KR100355130B1 (ko) * | 1992-09-18 | 2003-01-30 | 야마노우치세이야쿠 가부시키가이샤 | 하이드로겔서방성정제 |
| US20080075781A1 (en) * | 1992-11-25 | 2008-03-27 | Purdue Pharma Lp | Controlled release oxycodone compositions |
| KR0168715B1 (ko) * | 1992-11-30 | 1999-01-15 | 밋첼 아이. 커시너 | 맛을 차단하는 약제학적 조성물 |
| US5431916A (en) * | 1993-04-29 | 1995-07-11 | The Procter & Gamble Company | Pharmaceutical compositions and process of manufacture thereof |
| US20070275062A1 (en) * | 1993-06-18 | 2007-11-29 | Benjamin Oshlack | Controlled release oxycodone compositions |
| US5681873A (en) * | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
| DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
| US5840338A (en) * | 1994-07-18 | 1998-11-24 | Roos; Eric J. | Loading of biologically active solutes into polymer gels |
| US5603955A (en) * | 1994-07-18 | 1997-02-18 | University Of Cincinnati | Enhanced loading of solutes into polymer gels |
| US8226598B2 (en) * | 1999-09-24 | 2012-07-24 | Tolmar Therapeutics, Inc. | Coupling syringe system and methods for obtaining a mixed composition |
| DE10015479A1 (de) * | 2000-03-29 | 2001-10-11 | Basf Ag | Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität |
| US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| US7838032B2 (en) * | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
| US6955821B2 (en) * | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
| US8012504B2 (en) * | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| AU2002221412B2 (en) | 2000-12-05 | 2006-04-13 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
| MY142204A (en) * | 2002-07-25 | 2010-10-29 | Pharmacia Corp | Pramipexole once-daily dosage form |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| UA88477C2 (ru) * | 2004-08-13 | 2009-10-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение |
| ME01316B (me) * | 2004-08-13 | 2013-12-20 | Boehringer Ingelheim Int | Formulacija tablete sa produženim oslobađanjem koji sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so |
| EP1812025B1 (en) | 2004-11-02 | 2012-09-05 | Chr. Hansen A/S | Stabilized bacteriophage formulations |
| KR100753480B1 (ko) * | 2006-01-27 | 2007-08-31 | 씨제이 주식회사 | 잘토프로펜 함유 서방성 정제 및 그 제조방법 |
| US20090098202A1 (en) * | 2006-02-10 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Extended Release Formulation |
| US20090041844A1 (en) * | 2006-02-10 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Modified Release Formulation |
| EP2063862A2 (en) * | 2006-09-04 | 2009-06-03 | Matrix Laboratories Ltd | Pharmaceutical formulation for use in hiv therapy |
| GB2460915B (en) * | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| GB201506755D0 (en) | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| EP3364955B1 (en) | 2015-10-09 | 2022-04-20 | RB Health (US) LLC | Pharmaceutical formulation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3096248A (en) * | 1959-04-06 | 1963-07-02 | Rexall Drug & Chemical Company | Method of making an encapsulated tablet |
| US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
| BE604564A (cg-RX-API-DMAC7.html) * | 1960-06-06 | |||
| US3158538A (en) * | 1961-02-23 | 1964-11-24 | White Lab Inc | Antidiarrheal compositions and method of using |
| US3328256A (en) * | 1963-05-27 | 1967-06-27 | William E Gaunt | Spherical beads and their production |
| DE1467781A1 (de) * | 1963-07-15 | 1968-12-05 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe |
| US3346449A (en) * | 1963-09-27 | 1967-10-10 | Hoffmann La Roche | d-methorphan compositions and methods of making same |
| US3330729A (en) * | 1963-10-04 | 1967-07-11 | Goodrich Co B F | Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent |
-
1967
- 1967-04-07 US US629066A patent/US3458622A/en not_active Expired - Lifetime
-
1968
- 1968-03-26 SE SE04015/68A patent/SE353019B/xx unknown
- 1968-04-04 NL NL6804772A patent/NL6804772A/xx not_active Application Discontinuation
- 1968-04-05 DK DK153068AA patent/DK123071B/da not_active IP Right Cessation
- 1968-04-05 FR FR1588801D patent/FR1588801A/fr not_active Expired
- 1968-04-07 GB GB04720/68A patent/GB1235543A/en not_active Expired
- 1968-04-08 DE DE19681767170 patent/DE1767170A1/de not_active Withdrawn
- 1968-04-19 FR FR148671A patent/FR8060M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR8060M (cg-RX-API-DMAC7.html) | 1970-07-06 |
| US3458622A (en) | 1969-07-29 |
| SE353019B (cg-RX-API-DMAC7.html) | 1973-01-22 |
| FR1588801A (cg-RX-API-DMAC7.html) | 1970-03-16 |
| DK123071B (da) | 1972-05-15 |
| NL6804772A (cg-RX-API-DMAC7.html) | 1968-10-08 |
| DE1767170A1 (de) | 1971-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU570712B2 (en) | Crosslinked, porous polymers for controlled drug delivery | |
| AU459338B2 (en) | New esters, their production, and their medicinal use | |
| GB1135966A (en) | Improvements in or relating to sustained-release medicaments | |
| CA951205A (en) | Sterile disposable medicament administration system | |
| FI942922A0 (fi) | Asetyylisalisyylihappoa sisältävä ihon läpi tapahtuva antojärjestelmä antitromboottiseen terapiaan ja syövän ehkäisyyn | |
| CA927993A (en) | Copolymers of oligoesters having maleic acid end groups and vinyl monomers | |
| CA930668A (en) | Bandage for administering drugs | |
| AU468532B2 (en) | NEW l-IMIDAZOLYL-METHANEPHOSPHONIC ACID ESTERS, THEIR PRODUCTION, AND THEIR MEDICINAL USE | |
| CA957442A (en) | Tertiary aminohydroxyalkyl esters of carboxylic acid polymers, their preparation and use | |
| CA1007638A (en) | Phenylimino-3-aza-1-thia-cycloalkanes, their preparation, and their medicinal use | |
| GB1263392A (en) | Sustained release drug composition | |
| CA1019897A (en) | Process for the bulk polymerization of vinyl acetate and bulk copolymerization of vinyl acetate with vinyl esters | |
| AU456916B2 (en) | New sulphonic acid esters, their preparation, and their medicinal use | |
| AU469277B2 (en) | Drug delivery device | |
| CA918668A (en) | Pyrazolyl esters, a process for their preparation, and their use as insecticides and acaricides | |
| IL39223A0 (en) | Methacryloxy-sulfonic acid monomers and polymers,their preparation and use | |
| AU467033B2 (en) | Device for administration on gel medication to the urethral tract | |
| NZ184141A (en) | Pharmaceutical tablet formulation containing anti-allergic drug | |
| AU460748B2 (en) | Medical liquid administration set for rate or volume delivery | |
| AU421871B2 (en) | Multifunctional polymerization initiators and preparation thereof | |
| AU467246B2 (en) | Drug delivery device | |
| ZA742682B (en) | Drug delivery preparation with controlled release time and rate | |
| FR2019264A1 (en) | Treatment of cyseinic lithiase using dithioss- - licylic acid | |
| GB1153014A (en) | Improvements in or relating to An Oral Dose for the Treatment of Tuberculosis | |
| CA862922A (en) | Iff active readout control and display system |